Cargando…

Hypoadiponectinemia and Insulin Resistance are Associated with Nonalcoholic Fatty Liver Disease

We investigated the association between nonalcoholic fatty liver disease (NAFLD) and plasma adiponectin levels and insulin resistance. We recruited study subjects among one hundred and eighty one persons who were examined abdominal ultrasound at routine screening tests. A standard interview (consump...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Dokyoung, Lee, Seung Hwan, Park, Hye Soon, Lee, Ji Hoon, Park, Jin Seo, Cho, Kyung Hwan, Kim, Seon Mee
Formato:	Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2005
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2782197/ https://www.ncbi.nlm.nih.gov/pubmed/15953863 http://dx.doi.org/10.3346/jkms.2005.20.3.421

Ejemplares similares

Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
por: Baek, Jung-Hwan, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease and the risk of insulin-requiring gestational diabetes
por: You, Sang Youn, et al.
Publicado: (2021)

Hypoadiponectinemia in Patients With Paroxysmal Atrial Fibrillation
por: Choi, Byung Joo, et al.
Publicado: (2012)

Cardiovascular Risk Is Elevated in Lean Subjects with Nonalcoholic Fatty Liver Disease
por: Kim, Yuna, et al.
Publicado: (2022)

Jwa Kum Whan Attenuates Nonalcoholic Fatty Liver Disease by Modulating Glucose Metabolism and the Insulin Signaling Pathway
por: Lim, Dong-Woo, et al.
Publicado: (2019)

Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Hye Won, et al.
Publicado: (2016)

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
por: Kwak, Min-Sun, et al.
Publicado: (2012)

KLHL3 deficiency in mice ameliorates obesity, insulin resistance, and nonalcoholic fatty liver disease by regulating energy expenditure
por: Jang, Ju-hong, et al.
Publicado: (2022)

Pancreatic hyperechogenicity associated with hypoadiponectinemia and insulin resistance: A Japanese population study
por: Makino, Naohiko, et al.
Publicado: (2016)

Liver Stiffness-Based Risk Prediction Model for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease
por: Lee, Jae Seung, et al.
Publicado: (2021)

Correspondence on Editorial regarding “Screening and prediction of nonalcoholic fatty liver disease using a peripheral insulin resistance index: Potential benefits and limitations”
por: Lee, Jun-Hyuk, et al.
Publicado: (2023)

Noninvasive imaging biomarkers for liver fibrosis in nonalcoholic fatty liver disease: current and future
por: Yu, Jung Hwan, et al.
Publicado: (2023)

Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
por: Yu, Su Jong, et al.
Publicado: (2015)

Factors Associated or Related to with Pathological Severity of Nonalcoholic Fatty Liver Disease
por: Park, Kyung Sik, et al.
Publicado: (2004)

Interobserver Agreement on Pathologic Features of Liver Biopsy Tissue in Patients with Nonalcoholic Fatty Liver Disease
por: Jung, Eun Sun, et al.
Publicado: (2016)

Triglyceride Glucose-Waist Circumference Is Superior to the Homeostasis Model Assessment of Insulin Resistance in Identifying Nonalcoholic Fatty Liver Disease in Healthy Subjects
por: Kim, Hwi Seung, et al.
Publicado: (2021)

Hypoadiponectinemia as a marker of increased cardiovascular risk in patients with non-alcoholic fatty liver disease: correlation with albumin/creatinine ratio
por: Assem, Maha, et al.
Publicado: (2020)

Development and validation of a nonalcoholic fatty liver disease-based self-diagnosis tool for diabetes
por: Kim, Hye Jun, et al.
Publicado: (2022)

The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults
por: Ju, Deok Yun, et al.
Publicado: (2013)

Effects of Pioglitazone on Nonalcoholic Fatty Liver Disease in the Absence of Constitutive Androstane Receptor Expression
por: Ahn, Hwa Young, et al.
Publicado: (2018)

Association between Sarcopenic Obesity Status and Nonalcoholic Fatty Liver Disease and Fibrosis
por: Song, Wolhwa, et al.
Publicado: (2023)

Triglyceride Glucose Index Is Superior to the Homeostasis Model Assessment of Insulin Resistance for Predicting Nonalcoholic Fatty Liver Disease in Korean Adults
por: Lee, Sang Bae, et al.
Publicado: (2019)

Nonalcoholic fatty liver disease is associated with coronary artery calcium score in diabetes patients with higher HbA1c
por: Kwak, Min-Sun, et al.
Publicado: (2015)

Ginseng Saponin Enriched in Rh1 and Rg2 Ameliorates Nonalcoholic Fatty Liver Disease by Inhibiting Inflammasome Activation
por: Wang, Feng, et al.
Publicado: (2021)

Association of Change in Smoking Status and Subsequent Weight Change with Risk of Nonalcoholic Fatty Liver Disease
por: Jeong, Seogsong, et al.
Publicado: (2023)

Implication of Nonalcoholic Fatty Liver Disease, Metabolic Syndrome, and Subclinical Inflammation on Mild Renal Insufficiency
por: Nam, Ga Eun, et al.
Publicado: (2018)

Hypoadiponectinemia and the presence of metabolic syndrome in patients with chronic kidney disease: results from the KNOW-CKD study
por: Yoon, Chang-Yun, et al.
Publicado: (2016)

Application of body composition zones in boys with nonalcoholic fatty liver disease
por: Choi, Minhye, et al.
Publicado: (2019)

Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome
por: Di Chiara, Tiziana, et al.
Publicado: (2012)

Diagnostic Performance of the Fibrosis-4 Index and Nonalcoholic Fatty Liver Disease Fibrosis Score in Lean Adults With Nonalcoholic Fatty Liver Disease
por: Park, Huiyul, et al.
Publicado: (2023)

Prediction of Advanced Fibrosis in Nonalcoholic Fatty Liver Disease: An Enhanced Model of BARD Score
por: Lee, Tae Hoon, et al.
Publicado: (2013)

Nonalcoholic fatty liver disease and insulin resistance in children
por: Song, Kyungchul, et al.
Publicado: (2023)

Association of Serum Adipocyte-Specific Fatty Acid Binding Protein with Fatty Liver Index as a Predictive Indicator of Nonalcoholic Fatty Liver Disease
por: Jeon, Won Seon, et al.
Publicado: (2013)

Increased Selenoprotein P Levels in Subjects with Visceral Obesity and Nonalcoholic Fatty Liver Disease
por: Choi, Hae Yoon, et al.
Publicado: (2013)

Nonalcoholic Fatty Liver Disease and Diabetes: Part II: Treatment
por: Kim, Kyung-Soo, et al.
Publicado: (2019)

High Sodium Intake, as Assessed by Urinary Sodium Excretion, Is Associated with Nonalcoholic Fatty Liver Disease or Sarcopenia
por: Han, Eugene, et al.
Publicado: (2023)

Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis
por: Yoon, Sang Jun, et al.
Publicado: (2023)

Positive association between nonalcoholic fatty liver disease and growth hormone deficiency in patients with nonfunctioning pituitary adenoma
por: Hwang, Yoon-a, et al.
Publicado: (2023)

Nonalcoholic fatty liver disease is a risk factor for large-for-gestational-age birthweight
por: Lee, Seung Mi, et al.
Publicado: (2019)

Pilot study: asymptomatic hyperuricemia patients with obesity and nonalcoholic fatty liver disease have increased risk of double contour sign
por: Min, Hong Ki, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e9h2ve7qgs9u5ibcqtfa0dauh1